Summit Therapeutics clinical trials we track

Check company identity source

Phase 3 5 trials

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters
Phase III Study of AK112 for NSCLC Patients

NCT06396065 · Summit Therapeutics

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 31 Dec 2025. After: 12 Apr 2025.

Check registry source